Wellness That Matters: Black Health News & Community Care
- Researchers renamed PCOS to PMOS to better reflect its endocrine and metabolic nature.
- PMOS is a multifaceted endocrine and metabolic syndrome involving insulin, androgen, neuroendocrine, and ovarian hormone disturbances.
- The name change seeks to reduce stigma, speed diagnosis, coordinate care, and advance research and policy for better outcomes.
Researchers have renamed polycystic ovary syndrome (PCOS) to polyendocrine metabolic ovarian syndrome (PMOS). People suffering from unwanted facial hair, hyperpigmentation, thinning hair, irregular periods, weight gain, and acne might be on their way to getting some relief because of this reclassification. The change may help provide clarity to patients and healthcare providers.
PMOS Impacts One in Eight Women
PMOS is extremely common and impacts one in eight women. Ovarian dysfunction is a defining feature of PMOS, but it is not the only feature. Some cases do not include their disruption at all.
PCOS has impacted the lives of many, including celebrities like Lori Harvey, Keke Palmer, and Victoria Monet. PEOPLE reported that Monet shared the way that PCOS made her feel. “I usually am so critical and frustrated by it because PCOS has me really messed up,” said the “On My Mama” singer.
Harvey opened up about the way that her symptoms were overlooked and dismissed by her doctors. Keke Palmer has been transparent about the way that acne plagued her adolescence, hurting her personally and professionally.
Why the Change?
According to a May 2026 article from The Lancet, “the term PCOS is inaccurate, implying pathological ovarian cysts, obscuring diverse endocrine and metabolic features, and contributing to delayed diagnosis, fragmented care, and stigma, while curtailing research and policy framing.”
Metabolic health is deeply important to a person’s quality of life. PMOS is a metabolic syndrome, not a gynecological one.
A Reflection of the Research
That article reflected a consensus that researchers came to after years of the misnomer. It corrected outdated ideas about the condition that tied it to gender and ignored other factors. “PCOS has long been primarily perceived as a gynecological or ovarian disorder; however, mounting research, evidence synthesis, and International Guidelines have shown that PCOS is underpinned by endocrine disturbances in insulin, androgens, and neuroendocrine and ovarian hormones,” The Lancet continued.
It added that “In modern medical practice and research, PCOS is recognized as a multifaceted disorder that involves hormonal and metabolic imbalances, often extending beyond just the ovaries. While ovarian cysts can be a characteristic feature of PCOS, they are not present in all cases, and the condition’s impact on an individual’s overall health goes well beyond the ovaries.”
Why Language Matters
Language is crucial in all healthcare matters. It can erect barriers that make it difficult for patients to talk about what they are experiencing.
Disconnecting PMOS from the stigma associated with ovaries could have huge implications for people who do not even know they are affected by the condition. Research has indicated that men may also be affected by the condition.
Better Understanding Leads to Better Care
The name change was a long time coming. Some in the scientific community have been advocating for a change to the condition’s title for years. The AP reported that it had been over a decade since patients and experts had been working together to push through the change. “The hope was that with a more comprehensive and accurate name change, it would start to enable and push better care,” said Dr. Melanie Cree, one of the authors of The Lancet article.
In 2024, an article from Clinical Medicine Insights: Endocrinology and Diabetes championed the idea of renaming PCOS by summarizing the arguments for it, stating that “The term’ Polycystic Ovary Syndrome’ can be misleading, prompting many within the medical community and advocacy groups to advocate for a name change. Critics argue that this terminology can complicate understanding and awareness of the disease among patients.”
It explained what issues the name presented.
“The primary concern is that PCOS emphasizes the ovarian aspect, fostering the misconception that PCOS is merely a gynecological disorder. In reality, PCOS impacts multiple organ systems, particularly metabolic health. Patients frequently experience insulin resistance, weight gain, irregular menstrual cycles, and hirsutism—symptoms that extend beyond ovarian dysfunction. In light of these issues, there is increasing support for renaming PCOS to reflect its systemic implications better and minimize confusion. The current name may hinder understanding and potentially lead to inadequate disease management,” continued the Journal.
Addressing Outdated Ideas About Women’s Health
Ovaries have played an outsized role in medical classification since the beginning of the medical industry. Women were once labeled with the bogus diagnosis of hysteria when they misbehaved due to medical bias. Any behavior that their families didn’t approve of could be deemed an erratic display of side effects from their ovaries existing in their bodies. The Lancet argues that the previous name for the condition is part of why so many people suffering received delayed diagnoses, experienced patient dissatisfaction, and were left with huge gaps in the knowledge needed to care for themselves. This renaming is a step towards anyone impacted by this condition getting the help they need.
Resources
Clinical Medicine Insights: Endocrinology and Diabetes
Read the full article on the original site
